Published in JAMA on November 04, 1974
Primary cardiac tumors. Ann Surg (1980) 4.00
Cardiac myxomas: a clinicopathologic profile. Am J Pathol (1980) 2.74
Atrial myxoma: a review of the neurological complications, metastases, and recurrences. J Neurol Neurosurg Psychiatry (1978) 1.35
CT for intracardiac thrombi and tumors. Int J Cardiovasc Imaging (2005) 0.93
Cardiovascular assessment of falls in older people. Clin Interv Aging (2006) 0.91
Primary cardiac sarcoma presenting as acute left-sided heart failure. J Community Hosp Intern Med Perspect (2014) 0.91
Systemic septic embolisation secondary to an atrial myxoma in a young woman. Emerg Radiol (2006) 0.87
Right ventricular thrombus: clinical and diagnostic features. Tex Heart Inst J (1983) 0.87
Cardiac myxoma originating from the anterior mitral valve leaflet. J Cardiovasc Ultrasound (2011) 0.82
Neoplasms involving the heart, their simulators, and adverse consequences of their therapy. Proc (Bayl Univ Med Cent) (2001) 0.79
Left ventricular outflow tract myxoma accompanied by dextrocardia with situs inversus: a case report. Int J Cardiovasc Imaging (2006) 0.76
Two-dimensional echocardiography in the diagnosis of unusual left atrial myxomas. Cardiovasc Dis (1980) 0.76
ECHOCARDIOGRAPHIC CASE PRESENTATION: LEFT ATRIAL MYXOMA. Cardiovasc Dis (1976) 0.76
Unusual combination of total occlusion of left main coronary artery and heart failure with pulmonary hemosiderosis: case report. Tex Heart Inst J (1983) 0.75
Acute pulmonary edema caused by a giant atrial myxoma. Case Rep Med (2013) 0.75
Jaundice, hepatosplenomegaly and liver failure in a 60-year-old woman. West J Med (1981) 0.75
Left atrial myxoma: new perspectives in the diagnosis of murmur free cases. Br Heart J (1986) 0.75
Left atrial myxoma in a child with unique presentation: chest pain. Pediatr Cardiol (2010) 0.75
T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med (1996) 8.59
Surgical management of aneurysms of the ascending aorta. Including those associated with aortic valvular incompetence. Surg Clin North Am (1966) 6.84
Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A (1992) 6.37
The product of a newly identified gene, gInF, is required for synthesis of glutamine synthetase in Salmonella. Proc Natl Acad Sci U S A (1977) 5.19
Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A (2004) 5.09
Nitrogen control in Salmonella: regulation by the glnR and glnF gene products. Proc Natl Acad Sci U S A (1979) 4.79
Sinus of Valsalva aneurysm or fistula: management and outcome. Ann Thorac Surg (1999) 4.78
Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med (1999) 4.37
Improvement of retardates' mealtime behaviors by timeout procedures using multiple baseline techniques. J Appl Behav Anal (1970) 3.97
Primary cardiac sarcomas. Ann Thorac Surg (1991) 3.61
Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science (1991) 3.56
Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA (1997) 3.51
Congenital malformations of the coronary arteries: the Texas Heart Institute experience. Ann Thorac Surg (1992) 3.31
Surgical management of 56 patients with congenital coronary artery fistulas. Ann Thorac Surg (1983) 3.08
Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J Exp Med (1991) 3.04
Valvular heart disease: recommendations for investigation and management. Summary of guidelines produced by a working group of the British Cardiac Society and the Research Unit of the Royal College of Physicians. J R Coll Physicians Lond (1997) 2.83
Antibiotic prophylaxis in gastrointestinal endoscopy. Gut (2009) 2.65
Searching for autolysin functions. Characterization of a pneumococcal mutant deleted in the lytA gene. Eur J Biochem (1986) 2.58
The training and generalization of a conversational speech form in nonverbal retardates. J Appl Behav Anal (1974) 2.55
Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol (1969) 2.53
Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol Microbiol (1992) 2.50
Clinical characteristics and outcome of patients with early (<2 h), intermediate (2-4 h) and late (>4 h) presentation treated by primary coronary angioplasty or thrombolytic therapy for acute myocardial infarction. Eur Heart J (2002) 2.49
Coronary artery anomalies: a review of more than 10,000 patients from the Clayton Cardiovascular Laboratories. Tex Heart Inst J (1988) 2.48
Normal flow (TIMI-3) before mechanical reperfusion therapy is an independent determinant of survival in acute myocardial infarction: analysis from the primary angioplasty in myocardial infarction trials. Circulation (2001) 2.43
Myocardial bridges: a review. Prog Cardiovasc Dis (1983) 2.35
Surgical treatment of cardiac tumors: a 25-year experience. Ann Thorac Surg (1990) 2.34
Structural organization of virulence-associated plasmids of Yersinia pestis. J Bacteriol (1998) 2.22
Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp Med (1995) 2.19
Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties. J Neurochem (2005) 2.14
Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res (1999) 2.09
Extracranial carotid artery aneurysms: Texas Heart Institute experience. J Vasc Surg (2000) 2.07
Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II) Lancet (1998) 2.06
Echocardiographic features of secondary left ventricular hypertrophy. Br Heart J (1979) 2.04
Prognostic indices for survival during postcardiotomy intra-aortic balloon pumping. Methods of scoring and classification, with implications for left ventricular assist device utilization. J Thorac Cardiovasc Surg (1977) 1.96
Dysrhythmias after Mustard's operation for transposition of the treat arteries. Am J Cardiol (1972) 1.89
The surgery of biliary atresia. Ann Surg (1989) 1.74
Ascending aorta-abdominal aorta bypass: indications, technique, and report of 12 patients. Ann Thorac Surg (1977) 1.73
Late embolization of prosthetic mitral valve occluder with survival following reoperation. Ann Thorac Surg (1975) 1.73
Definitive surgical treatment of anomalous origin of left coronary artery from pulmonary artery: indications and results. J Thorac Cardiovasc Surg (1966) 1.71
Coronary artery bypass for unsuccessful percutaneous transluminal coronary angioplasty. J Thorac Cardiovasc Surg (1984) 1.71
Lowering the hemoglobin threshold for transfusion in coronary artery bypass procedures: effect on patient outcome. Transfusion (1999) 1.69
Ischemic contracture of the heart: "stone heart". Am J Cardiol (1972) 1.67
Risk factors for cardiac operations in adult Jehovah's Witnesses. Ann Thorac Surg (1991) 1.65
Cardiovascular surgery in Jehovah's Witnesses. Report of 542 operations without blood transfusion. JAMA (1977) 1.63
Biliary atresia and the polysplenia syndrome. J Pediatr Surg (1991) 1.62
Cardiac transplantation for advanced acquired heart disease. J Cardiovasc Surg (Torino) (1969) 1.62
Supravalvar aortic stenosis: a 29-year review of surgical experience. Ann Thorac Surg (1991) 1.60
Early systolic closure of the aortic valve in patients with hypertrophic subaortic stenosis and discrete subaortic stenosis. Correlation with preoperative and postoperative hemodynamics. Am J Cardiol (1978) 1.60
Correlation between functional and structural assessments of the optic nerve and retina in multiple sclerosis patients. Neurophysiol Clin (2010) 1.59
[Nasogastric tube: intratracheal malposition and entrapment in a bronchial suture]. Ann Fr Anesth Reanim (1998) 1.59
Training in cardiology: the future. Br Heart J (1995) 1.54
An integrated metric physical map of human chromosome 19. Nat Genet (1995) 1.54
Chronic eosinophilic pneumonia as a presenting feature of Churg-Strauss syndrome. Eur Respir J (1994) 1.53
Estimation of the length of cell cycle phases from asynchronous cultures of Saccharomyces cerevisiae. Exp Cell Res (1976) 1.52
Denton Arthur Cooley, MD: a conversation with the editor. Interview by William Clifford Roberts. Am J Cardiol (1997) 1.50
Tuberculosis skin testing, anergy and protein malnutrition in Peru. Int J Tuberc Lung Dis (2005) 1.48
Biliary atresia registry, 1976 to 1989. J Pediatr Surg (1990) 1.48
Cor triatriatum: operative results in 25 patients. Ann Thorac Surg (1983) 1.47
Aortocoronary saphenous vein bypass. Results in 1,492 patients, with particular reference to patients with complicating features. Ann Thorac Surg (1973) 1.47
Transplantation of the human heart. Report of four cases. JAMA (1968) 1.46
Congenital anomalies of the coronary arteries: anatomy, pathology, and surgical treatment. Surgery (1966) 1.45
Interleukin (IL)-10 and IL-6 are produced in vivo by non-Hodgkin's lymphoma cells and act as cooperative growth factors. Cancer Res (1996) 1.45
Primary cardiac tumors in infants and children: immediate and long-term operative results. Ann Thorac Surg (1996) 1.44
Cardiac tumors. Clinical spectrum and prognosis of lesions other than classical benign myxoma in 20 patients. J Thorac Cardiovasc Surg (1984) 1.43
Severe intravascular hemolysis after aortic valve replacement: reversal by left ventricular apico-abdominal aortic composite conduit. J Thorac Cardiovasc Surg (1977) 1.43
Atrial myxoma. Surgical considerations. J Thorac Cardiovasc Surg (1973) 1.42
Carotid endarterectomy without temporary intraluminal shunt. Study of 309 consecutive operations. Ann Surg (1980) 1.42
Clinical course and late prognosis of treated subacute massive, acute minor, and chronic pulmonary thromboembolism. Br Heart J (1977) 1.41
Comparison of Nottingham Health Profile (NHP) scores with exercise duration and measures of ischaemia during treadmill exercise testing in patients with coronary artery disease. Eur Heart J (1995) 1.41
Pulmonary embolectomy, heparin, and streptokinase: their place in the treatment of acute massive pulmonary embolism. Am Heart J (1977) 1.41
Risk factors associated with preterm delivery after fetoscopic laser ablation for twin-twin transfusion syndrome. Ultrasound Obstet Gynecol (2014) 1.40
Cyanosis after surgical correction of pulmonary valve stenosis: an old problem revisited. Tex Heart Inst J (1985) 1.40
An unusual complication of left ventricular pseudoaneurysm: hemoptysis. Chest (1988) 1.40
Emergency coronary stenting for acute occlusive dissection of the left main coronary artery. Cathet Cardiovasc Diagn (1993) 1.39
Diverticulum or aneurysm of left ventricle. Am J Cardiol (1973) 1.39
Predictors of short term clinical and angiographic outcome after coronary angioplasty for acute myocardial infarction. Cathet Cardiovasc Diagn (1995) 1.39
Cardiac transplantation in Puerto Rican patients at the Texas Heart Institute. Bol Asoc Med P R (1991) 1.39
FDF03, a novel inhibitory receptor of the immunoglobulin superfamily, is expressed by human dendritic and myeloid cells. J Immunol (2000) 1.39
Heparin-coated Palmaz-Schatz stents in human coronary arteries. Early outcome of the Benestent-II Pilot Study. Circulation (1996) 1.39
Organ transplantation for advanced cardiopulmonary disease. Ann Thorac Surg (1969) 1.38
APCs express DCIR, a novel C-type lectin surface receptor containing an immunoreceptor tyrosine-based inhibitory motif. J Immunol (1999) 1.38
Survival after aberrant right subclavian artery-esophageal fistula: case report and literature review. J Vasc Surg (1996) 1.38
Coronary artery bypass in patients over 70 years of age: indications and results. Am J Cardiol (1975) 1.37
Long-term prognosis of treated acute massive pulmonary embolism. Br Heart J (1977) 1.37
Management of symptomatic infants with anomalous origin of the left coronary artery from the pulmonary artery. Am J Cardiol (1981) 1.36
Tumors of the heart and pericardium. Curr Probl Cardiol (1999) 1.36
Cyclooxygenase-2 is widely expressed in atherosclerotic lesions affecting native and transplanted human coronary arteries and colocalizes with inducible nitric oxide synthase and nitrotyrosine particularly in macrophages. Arterioscler Thromb Vasc Biol (1999) 1.35
An intracorporeal (abdominal) left ventricular assist device. Initial clinical trials. Arch Surg (1977) 1.34
Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction. J Am Coll Cardiol (1987) 1.34
Lysyl oxidase deficiency in Ehlers-Danlos syndrome type V. Connect Tissue Res (1975) 1.33